China Red Medical (300981.SZ) plans to invest in Southeast Asian company SEA3 to expand its overseas business opportunities.

Zhixing Financial News APP, Zhongrong Medical (300981.SZ) announced that, in order to implement the company's strategic planning, expand overseas business space, and enhance the company's overall competitive strength, it has agreed to sell 75% of the equity of Southeast Asian company SEA3 (hereinafter referred to as the "Target Company") for a total of RMB 6.97 million in cash using its own funds. The company also agreed that after the equity transfer, Zhongrong International (Hong Kong) Trading Co., Ltd. (hereinafter referred to as "Zhongrong Hong Kong", a wholly-owned subsidiary of the company) and Guilin Hengbao Protection International Co., Ltd. (hereinafter referred to as "Hengbao International", fully owned by Guilin Hengbao Health Protection Co., Ltd., a controlling subsidiary of the company with 70% stake) will use their own funds to inject a total of RMB 75.67 million into SEA3 company, increase capital by RMB 52.9755 million and RMB 22.7038 million respectively.